Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Grant/Award of 19,117 shares.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Entera Bio Ltd. | Grant/Award | 19,117 | n/a |
| Jul 28, 2026 | OPKO HEALTH, INC. (OPK) | Tax Withholding | 53,266 | $65.0K |
| Jun 26, 2026 | Niagen Bioscience, Inc. (NAGE) | Grant/Award | 31,746 | n/a |
| Jun 11, 2026 | Eloxx Pharmaceuticals, Inc. (ELOX) | Grant/Award | 4,018 | n/a |
| Jun 5, 2026 | Red Violet, Inc. (RDVT) | Grant/Award | 2,179 | n/a |
| May 8, 2026 | Eloxx Pharmaceuticals, Inc. (ELOX) | Exercise/Conversion | 1,875 | n/a |
| Feb 17, 2026 | Entera Bio Ltd. | Purchase | 5,000 | $7.5K |
| Feb 11, 2026 | Entera Bio Ltd. | Purchase | 10,000 | $12.0K |
| Jan 13, 2026 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 16,410 | n/a |
| Dec 22, 2025 | Red Violet, Inc. (RDVT) | Grant/Award | 4,450 | n/a |